Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Nov 12, 2013, after the close
10-Q filed Nov 12, 2013, 43 days after period end · 0001144204-13-060498
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Revenue | $2.50K | $170.83K | $103.42K | — |
| Net Income | -$6.69M | -$2.58M | -$3.21M | -$3.93M |
| EPS Diluted | -$0.09 |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$0.04 |
| -$0.07 |
| -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
